News for 'ranbaxy-pharmaceuticals-inc'

Ranbaxy gets USFDA nod for Atenolol tabs

Ranbaxy gets USFDA nod for Atenolol tabs

Rediff.com2 Jan 2007

Ranbaxy Pharmaceuticals Inc said on Tuesday it has received US Food and Drug Administration's approval for manufacturing and marketing cardiovascular drug -- Atenolol tablets in the US.

Ranbaxy resumes supply of Atorvastatin tablets in US

Ranbaxy resumes supply of Atorvastatin tablets in US

Rediff.com1 Apr 2013

The company had stopped production of generic version of cholesterol lowering drug Lipitor last year as it investigated the issue of potential glass particles in certain lots of the drug.

Ranbaxy launches Lipitor's generic version in US

Ranbaxy launches Lipitor's generic version in US

Rediff.com1 Dec 2011

The launch came after final approval from the US health regulator to manufacture the generic version of Lipitor at Ranbaxy's wholly owned Ohm Laboratories facility in New Brunswick, New Jersey, as well as market the product.

Ranbaxy's US arm to face patent infringement suit

Ranbaxy's US arm to face patent infringement suit

Rediff.com11 May 2010

US-based Purdue Pharma has filed a patent infringement suit against India's largest drug company, Ranbaxy, after the latter's wholly-owned US subsidiary, Ranbaxy Pharmaceuticals Inc, applied for marketing approval of a low-cost version of Purdue's pain relieving medicine, Oxycodone.

Pfizer, Wyeth sue Ranbaxy over drug

Pfizer, Wyeth sue Ranbaxy over drug

Rediff.com3 May 2010

Pfizer, the world's largest drug company, and Wyeth have sued Daiichi Sankyo-owned Ranbaxy Laboratories in a US court for infringing the patent rights of Wyeth's drug, Rapamune.

Ranbaxy gets FDA nod for Topiramate

Ranbaxy gets FDA nod for Topiramate

Rediff.com17 Dec 2004

Pharma major Ranbaxy Laboratories Ltd on Friday said it has received tentative approval from the US Food and Drug Administration to manufacture and market 25 mg, 100 mg and 200 mg Topiramate tablets.

Ranbaxy gets FDA nod for drugs

Ranbaxy gets FDA nod for drugs

Rediff.com9 Sep 2004

Ranbaxy Laboratories has received tentative approval from the US Food and Drug Administration to manufacture and market Fosinopril Sodium and Hydrochlorothiazide tablets in 10 mg/12.5 mg and 20 mg/12.5 mg strengths

Ranbaxy to appeal against quinapril order

Ranbaxy to appeal against quinapril order

Rediff.com30 Mar 2005

Ranbaxy Laboratories will file an appeal against a New Jersey district court order restraining Teva Pharmaceuticals and Ranbaxy Pharmaceuticals Inc from selling RPI's quinapril tablets (5, 10, 20, and 40 mg) on a challenge filed by Pfizer.

Ranbaxy bags cardio drug deal

Ranbaxy bags cardio drug deal

Rediff.com10 Dec 2004

Ranbaxy gets FDA nod for Modafinil

Ranbaxy gets FDA nod for Modafinil

Rediff.com23 Feb 2004

Ranbaxy Laboratories said on Monday that it has received tentative approval from the US Food and Drug Administration to manufacture and market Modafinil tablets, a generic of Cepahalon's Provigil.

Ranbaxy unveils Riomet in US

Ranbaxy unveils Riomet in US

Rediff.com11 Feb 2004

Ranbaxy gets final FDA nod for drug

Ranbaxy gets final FDA nod for drug

Rediff.com10 Jun 2004

Ranbaxy Laboratories on Thursday said that it had received final approval from US Food and Drug Administration to manufacture and market Ciprofloxacin.

Ranbaxy gets FDA nod for Isotretinoin capsules

Ranbaxy gets FDA nod for Isotretinoin capsules

Rediff.com23 Jun 2003

Ranbaxy Laboratories on Monday said it has received the US Food and Drug Administration's approval to manufacture and market Isotretinoin capsules, a generic version of Hoffman LaRoche's Accutane.